PFG Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
PFG Advisors's ARKG Position: Q3 2023 in Review
PFG Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 9,306 shares — an estimated $317K sold.
PFG Advisors first reported a position in ARKG in Q1 2020 and held it in 14 quarters. The position peaked at $5.28M in Q2 2021. 287 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.
- PFG Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
- PFG Advisors sold 9,306 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $317K.
- PFG Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 14 quarters.
- PFG Advisors's ARK Genomic Revolution ETF position peaked at $5.28M in Q2 2021.
- 287 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.
Based on PFG Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.